SJS Investment Consulting’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2
| Closed | -$120 | – | 1632 |
|
|
2023
Q3 | $120 | Hold |
2
| – | – | ﹤0.01% | 1521 |
|
|
2023
Q2 | $145 | Hold |
2
| – | – | ﹤0.01% | 1465 |
|
|
2023
Q1 | $148 | Sell |
2
-1
| -33% | -$74 | ﹤0.01% | 1410 |
|
|
2022
Q4 | $200 | Buy |
3
+1
| +50% | +$67 | ﹤0.01% | 1412 |
|
|
2022
Q3 | $0 | Buy |
+2
| New | – | ﹤0.01% | 1313 |
|